Thursday 4 June 2020
Home      All news      Contact us     
reuters - 12 days ago

NIH trial: Gilead s drug works best in COVID patients on oxygen

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.

Related news

Latest News
Hashtags:   

trial

 | 

Gilead

 | 

works

 | 

COVID

 | 

patients

 | 

oxygen

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources